Lacticaseibacillus rhamnosus Probio-M9 enhanced the antitumor response to anti-PD-1 therapy by modulating intestinal metabolites

鼠李糖乳杆菌 免疫系统 肠道菌群 免疫疗法 益生菌 动物双歧杆菌 肿瘤微环境 生物 细胞毒性T细胞 结直肠癌 代谢组 免疫 癌症免疫疗法 癌症研究 免疫学 癌症 双歧杆菌 医学 微生物学 代谢组学 乳酸菌 体外 细菌 生物信息学 生物化学 遗传学
作者
Guangqi Gao,Siyuan Shen,Tao Zhang,Jiachao Zhang,Shi Huang,Zhihong Sun,Heping Zhang
出处
期刊:EBioMedicine [Elsevier BV]
卷期号:91: 104533-104533 被引量:30
标识
DOI:10.1016/j.ebiom.2023.104533
摘要

Probiotics have been increasingly proposed for enhancing immune checkpoint blockade (ICB) treatments against cancer. However, its causal relationship with immunotherapeutic efficacy remains unclear, which promoted us to explore if and how probiotic Lacticaseibacillus rhamnosus Probio-M9 manipulates gut microbiome for expected outcomes.We evaluated the effects of Probio-M9 on the anti-PD-1 treatment against colorectal cancer in mice via a multi-omics approach. We defined the mechanisms of Probio-M9-mediated antitumor immunity by comprehensive analyses of metagenome and metabolites of commensal gut microbes as well as the immunologic factors and serum metabolome of the host.The results indicated that Probio-M9 intervention strengthened the anti-PD-1-based tumor inhibition. Both prophylactic and therapeutic administration of Probio-M9 showed conspicuous performance in controlling tumor growth with ICB treatment. The supplement of Probio-M9 modulated enhanced immunotherapy response through promoting beneficial microbes (e.g., Lactobacillus and Bifidobacterium animalis), producing beneficial metabolites including butyric acids in the gut, and accumulating blood-derived α-ketoglutaric acid, N-acetyl-l-glutamic acid and pyridoxine in particular, which promoted the infiltration and activation of cytotoxic T lymphocytes (CTLs) and suppressing the function of regulatory T cells (Tregs) in the tumor microenvironment (TME). Subsequently, we found that enhanced immunotherapeutic response was transmissible by transplanting either post-probiotic-treatment gut microbes or intestinal metabolites to new tumor-bearing mice.This study offered valuable insight into the causal role of Probio-M9 in correcting the defects in gut microbiota that compromised anti-PD-1 therapeutic efficacy, which can be used as an alternative synergetic agent with ICB for clinical cancer treatment.This research was supported by Research Fund for the National Key R&D Program of China (2022YFD2100702), Inner Mongolia Science and Technology Major Projects (2021ZD0014), and China Agriculture Research System of MOF and MARA.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
务实金毛完成签到 ,获得积分10
1秒前
NexusExplorer的应助被Tuniverse_采纳,获得10
1秒前
666完成签到 ,获得积分10
2秒前
科研废柴发布了新的文献求助10
2秒前
maomao发布了新的文献求助10
2秒前
重逢不太难完成签到,获得积分10
3秒前
无与伦比完成签到 ,获得积分0
4秒前
天天快乐的应助被qin202569采纳,获得10
4秒前
完美世界的应助被QiongBai520采纳,获得10
4秒前
111完成签到,获得积分10
5秒前
6秒前
6秒前
7秒前
jinhuanghuiyu完成签到,获得积分10
7秒前
可爱的函函的应助被巫凝天采纳,获得10
8秒前
爆米花的应助被初景采纳,获得10
8秒前
倪康琪完成签到,获得积分10
9秒前
笨笨迎蓉发布了新的文献求助10
9秒前
三线态乃春完成签到,获得积分10
10秒前
10秒前
GQ完成签到,获得积分10
11秒前
yqliu发布了新的文献求助10
11秒前
12秒前
藏识完成签到,获得积分10
13秒前
深情安青的应助被BernardGo采纳,获得10
13秒前
molihuakai的应助被ff采纳,获得10
13秒前
13秒前
14秒前
Bambam完成签到,获得积分10
15秒前
ZeKaWa的应助被斯多姆采纳,获得10
16秒前
Akim的应助被刘星雨采纳,获得10
16秒前
17秒前
18秒前
无限觅风完成签到,获得积分10
19秒前
19秒前
iveuplife完成签到,获得积分10
19秒前
MISAYA发布了新的文献求助10
19秒前
123完成签到,获得积分10
19秒前
21秒前
铁路桥完成签到,获得积分10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175336
求助须知:如何正确求助?哪些是违规求助? 9567158
关于积分的说明 21790491
捐赠科研通 7769866
什么是DOI,文献DOI怎么找? 3431849
关于科研通互助平台的介绍 2556178
邀请新用户注册赠送积分活动 2477280